NEW YORK , Oct. 7, 2024 /PRNewswire/ -- Report with market evolution powered by AI- The global coronavirus test kits market size is estimated to grow by USD -6.8 billion from 2024-2028, according to Technavio.
The market is estimated to grow at a CAGR of -72.6% during the forecast period. Rising adoption of rapid coronavirus test kits is driving market growth, with a trend towards increasing demand for point-of-care diagnostics.
However, poor healthcare settings in developing countries poses a challenge. Key market players include Abbott Laboratories, Advaite Inc., BGI Group, Bio Rad Laboratories Inc.
, Biomedomics Inc, BioMerieux SA, Cellex Inc., Chembio Diagnostics Inc., Cue Health Inc.
, Danaher Corp., Dynamiker Biotechnology Tianjin Co. Ltd.
, F. Hoffmann La Roche Ltd., Mylab Discovery Solutions Pvt Ltd.
, QIAGEN N.V., QuidelOrtho Corp.
, Robert Bosch GmbH, Safecare Biotech Hangzhou Co. Ltd., Siemens AG, Thermo Fisher Scientific Inc.
, and Unisys Corp.. AI-Powered Market Evolution Insights.
Our comprehensive market report ready with the latest trends, growth opportunities, and strategic analysis- View your snapshot now Key Market Trends Fueling Growth The coronavirus disease has presented a significant challenge to healthcare systems worldwide, necessitating increased diagnostic capabilities. Authorities, including the World Health Organization (WHO), European Centre for Disease Prevention and Control (ECDC), and National Institutes of Health (NIH), are working to strengthen su.
